Is Compugen Ltd. (CGEN) a Buy, Sell, or Hold?
Compugen Ltd.
NASDAQ:CGEN
$2.355 USD
$0.06 (2.39%)
- Volume
- 74.89K
- Average Volume
- 485.85K
- Market Capitalization
- $222.67M
- P/E Ratio
- 6.42
- Dividend Yield
- 0.00%
- Price Target
- $5.00
- Year High
- $3.24
- Year Low
- $1.30
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.23
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
11
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
19
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 78000
CGEN Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
CGEN Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Levine Zurit | officer: SVP, Business Development | 2026-07-09 | M-Exempt | 0.8292 | 2026-07-13 |
| Levine Zurit | officer: SVP, Business Development | 2026-07-09 | S-Sale | 2.5 | 2026-07-13 |
| Levine Zurit | officer: SVP, Business Development | 2026-07-09 | M-Exempt | 0.8292 | 2026-07-13 |
| Levine Zurit | officer: SVP, Business Development | 2026-04-24 | M-Exempt | 1.15 | 2026-04-27 |
| Levine Zurit | officer: SVP, Business Development | 2026-04-24 | M-Exempt | 1.15 | 2026-04-27 |
| Levine Zurit | officer: SVP, Business Development | 2026-04-24 | S-Sale | 3.2 | 2026-04-27 |
| Ophir Eran | director, officer: President and CEO | 2026-04-24 | M-Exempt | 0.8292 | 2026-04-27 |
| Ophir Eran | director, officer: President and CEO | 2026-04-24 | M-Exempt | 0.8292 | 2026-04-27 |
| Ophir Eran | director, officer: President and CEO | 2026-04-24 | S-Sale | 3.2001 | 2026-04-27 |
| Ophir Eran | director, officer: President and CEO | 2026-04-14 | M-Exempt | 0.8292 | 2026-04-15 |
| Ophir Eran | director, officer: President and CEO | 2026-04-14 | M-Exempt | 0.8292 | 2026-04-15 |
| Ophir Eran | director, officer: President and CEO | 2026-04-14 | S-Sale | 2.9042 | 2026-04-15 |
| Levine Zurit | officer: SVP, Business Development | 2026-04-14 | M-Exempt | 1.15 | 2026-04-15 |
| Levine Zurit | officer: SVP, Business Development | 2026-04-14 | M-Exempt | 1.15 | 2026-04-15 |
| Levine Zurit | officer: SVP, Business Development | 2026-04-14 | S-Sale | 2.8 | 2026-04-15 |
| Levine Zurit | officer: SVP, Business Development | 2026-04-10 | M-Exempt | 1.15 | 2026-04-13 |
| Levine Zurit | officer: SVP, Business Development | 2026-04-10 | M-Exempt | 1.15 | 2026-04-13 |
| Levine Zurit | officer: SVP, Business Development | 2026-04-10 | M-Exempt | 0.8292 | 2026-04-13 |
| Levine Zurit | officer: SVP, Business Development | 2026-04-10 | S-Sale | 2.564 | 2026-04-13 |
| Levine Zurit | officer: SVP, Business Development | 2026-04-10 | M-Exempt | 0.8292 | 2026-04-13 |
| Levine Zurit | officer: SVP, Business Development | 2026-04-08 | M-Exempt | 1.15 | 2026-04-09 |
| Levine Zurit | officer: SVP, Business Development | 2026-04-08 | M-Exempt | 1.15 | 2026-04-09 |
| Levine Zurit | officer: SVP, Business Development | 2026-04-08 | M-Exempt | 0.8292 | 2026-04-09 |
| Levine Zurit | officer: SVP, Business Development | 2026-04-07 | M-Exempt | 0.8292 | 2026-04-09 |
| Levine Zurit | officer: SVP, Business Development | 2026-04-07 | S-Sale | 2.3 | 2026-04-09 |
| Levine Zurit | officer: SVP, Business Development | 2026-04-08 | S-Sale | 2.42 | 2026-04-09 |
| Levine Zurit | officer: SVP, Business Development | 2026-04-07 | M-Exempt | 0.8292 | 2026-04-09 |
| Levine Zurit | officer: SVP, Business Development | 2026-04-08 | M-Exempt | 0.8292 | 2026-04-09 |
| Levine Zurit | officer: SVP, Business Development | 2026-04-01 | M-Exempt | 1.15 | 2026-04-03 |
| Levine Zurit | officer: SVP, Business Development | 2026-04-01 | M-Exempt | 1.15 | 2026-04-03 |
| Levine Zurit | officer: SVP, Business Development | 2026-04-01 | M-Exempt | 0.8292 | 2026-04-03 |
| Levine Zurit | officer: SVP, Business Development | 2026-04-01 | S-Sale | 2.2 | 2026-04-03 |
| Levine Zurit | officer: SVP, Business Development | 2026-04-01 | M-Exempt | 0.8292 | 2026-04-03 |
| Ophir Eran | director, officer: President and CEO | 2026-04-01 | M-Exempt | 0.8292 | 2026-04-03 |
| Ophir Eran | director, officer: President and CEO | 2026-04-01 | M-Exempt | 0.8292 | 2026-04-03 |
| Ophir Eran | director, officer: President and CEO | 2026-04-01 | S-Sale | 2.2067 | 2026-04-03 |
| Levine Zurit | officer: SVP, Business Development | 2026-03-26 | M-Exempt | 0.8292 | 2026-03-30 |
| Levine Zurit | officer: SVP, Business Development | 2026-03-26 | S-Sale | 2.0368 | 2026-03-30 |
| Levine Zurit | officer: SVP, Business Development | 2026-03-26 | M-Exempt | 0.8292 | 2026-03-30 |
| ZWEIFACH SANFORD S | director | 2026-03-18 | 0 | 2026-03-18 | |
| ZWEIFACH SANFORD S | director | 2026-03-18 | 14.4 | 2026-03-18 | |
| ZWEIFACH SANFORD S | director | 2026-03-18 | 3.24 | 2026-03-18 | |
| ZWEIFACH SANFORD S | director | 2026-03-18 | 6.45 | 2026-03-18 | |
| ZWEIFACH SANFORD S | director | 2026-03-18 | 1.15 | 2026-03-18 | |
| ZWEIFACH SANFORD S | director | 2026-03-18 | 1.69 | 2026-03-18 | |
| ZWEIFACH SANFORD S | director | 2026-03-18 | 1.97 | 2026-03-18 | |
| ZWEIFACH SANFORD S | director | 2026-03-18 | 1.46 | 2026-03-18 | |
| Silberman David | officer: Chief Financial Officer | 2026-03-18 | 0 | 2026-03-18 | |
| Silberman David | officer: Chief Financial Officer | 2026-03-18 | 1.69 | 2026-03-18 | |
| Silberman David | officer: Chief Financial Officer | 2026-03-18 | 1.46 | 2026-03-18 | |
| Livnat Savitzky Kinneret | director | 2026-03-18 | 0 | 2026-03-18 | |
| Livnat Savitzky Kinneret | director | 2026-03-18 | 3.85 | 2026-03-18 | |
| Livnat Savitzky Kinneret | director | 2026-03-18 | 3.24 | 2026-03-18 | |
| Livnat Savitzky Kinneret | director | 2026-03-18 | 14.4 | 2026-03-18 | |
| Livnat Savitzky Kinneret | director | 2026-03-18 | 6.45 | 2026-03-18 | |
| Livnat Savitzky Kinneret | director | 2026-03-18 | 1.15 | 2026-03-18 | |
| Livnat Savitzky Kinneret | director | 2026-03-18 | 1.69 | 2026-03-18 | |
| Livnat Savitzky Kinneret | director | 2026-03-18 | 1.97 | 2026-03-18 | |
| Livnat Savitzky Kinneret | director | 2026-03-18 | 1.46 | 2026-03-18 | |
| Perry Eran | director | 2026-03-18 | 0 | 2026-03-18 | |
| Perry Eran | director | 2026-03-18 | 3.84 | 2026-03-18 | |
| Perry Eran | director | 2026-03-18 | 14.4 | 2026-03-18 | |
| Perry Eran | director | 2026-03-18 | 6.45 | 2026-03-18 | |
| Perry Eran | director | 2026-03-18 | 3.24 | 2026-03-18 | |
| Perry Eran | director | 2026-03-18 | 1.15 | 2026-03-18 | |
| Perry Eran | director | 2026-03-18 | 1.69 | 2026-03-18 | |
| Perry Eran | director | 2026-03-18 | 1.97 | 2026-03-18 | |
| Perry Eran | director | 2026-03-18 | 1.46 | 2026-03-18 | |
| Ophir Eran | director, officer: President and CEO | 2026-03-18 | 0 | 2026-03-18 | |
| Ophir Eran | director, officer: President and CEO | 2026-03-18 | 6.65 | 2026-03-18 | |
| Ophir Eran | director, officer: President and CEO | 2026-03-18 | 2.85 | 2026-03-18 | |
| Ophir Eran | director, officer: President and CEO | 2026-03-18 | 3.15 | 2026-03-18 | |
| Ophir Eran | director, officer: President and CEO | 2026-03-18 | 3.25 | 2026-03-18 | |
| Ophir Eran | director, officer: President and CEO | 2026-03-18 | 14.4 | 2026-03-18 | |
| Ophir Eran | director, officer: President and CEO | 2026-03-18 | 6.45 | 2026-03-18 | |
| Ophir Eran | director, officer: President and CEO | 2026-03-18 | 3.24 | 2026-03-18 | |
| Ophir Eran | director, officer: President and CEO | 2026-03-18 | 0.8292 | 2026-03-18 | |
| Ophir Eran | director, officer: President and CEO | 2026-03-18 | 1.15 | 2026-03-18 | |
| Ophir Eran | director, officer: President and CEO | 2026-03-18 | 1.69 | 2026-03-18 | |
| Ophir Eran | director, officer: President and CEO | 2026-03-18 | 1.46 | 2026-03-18 | |
| Ophir Eran | director, officer: President and CEO | 2026-03-18 | 1.38 | 2026-03-18 | |
| Mahler Michelle | officer: Chief Medical Officer | 2026-03-18 | 0 | 2026-03-18 | |
| Mahler Michelle | officer: Chief Medical Officer | 2026-03-18 | 0.8793 | 2026-03-18 | |
| Mahler Michelle | officer: Chief Medical Officer | 2026-03-18 | 1.69 | 2026-03-18 | |
| Mahler Michelle | officer: Chief Medical Officer | 2026-03-18 | 1.46 | 2026-03-18 | |
| Levine Zurit | officer: SVP, Business Development | 2026-03-18 | 0 | 2026-03-18 | |
| Levine Zurit | officer: SVP, Business Development | 2026-03-18 | 6.65 | 2026-03-18 | |
| Levine Zurit | officer: SVP, Business Development | 2026-03-18 | 2.85 | 2026-03-18 | |
| Levine Zurit | officer: SVP, Business Development | 2026-03-18 | 3.15 | 2026-03-18 | |
| Levine Zurit | officer: SVP, Business Development | 2026-03-18 | 3.8 | 2026-03-18 | |
| Levine Zurit | officer: SVP, Business Development | 2026-03-18 | 3.24 | 2026-03-18 | |
| Levine Zurit | officer: SVP, Business Development | 2026-03-18 | 14.4 | 2026-03-18 | |
| Levine Zurit | officer: SVP, Business Development | 2026-03-18 | 6.45 | 2026-03-18 | |
| Levine Zurit | officer: SVP, Business Development | 2026-03-18 | 0.8292 | 2026-03-18 | |
| Levine Zurit | officer: SVP, Business Development | 2026-03-18 | 1.15 | 2026-03-18 | |
| Levine Zurit | officer: SVP, Business Development | 2026-03-18 | 1.69 | 2026-03-18 | |
| Levine Zurit | officer: SVP, Business Development | 2026-03-18 | 1.46 | 2026-03-18 | |
| Kredo Russo Sharon | officer: SVP, Research & Discovery | 2026-03-18 | 0 | 2026-03-18 | |
| Kredo Russo Sharon | officer: SVP, Research & Discovery | 2026-03-18 | 1.64 | 2026-03-18 |